| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-06 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.19 | 3e-06 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.16 | 5e-06 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.16 | 9e-06 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.23 | 1e-05 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.12 | 2e-05 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.23 | 3e-05 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.16 | 4e-05 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.16 | 4e-05 |